DEEPCURRENTS INVESTMENT GROUP LLC
Q4 2021 Form 13-F
NEW YORK, NEW YORK
CIK 0001754535
· CRD 288159
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q4 2018
$3.2B Reported Value Total
DEEPCURRENTS INVESTMENT GROUP LLC reports 4 total accounts under management (AUM). There are 4 discretionary accounts valued at $4,434,037,806, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
1 fund
· $3.5B gross asset value
Hedge Fund: $3.5B
Source: Form ADV filed 2026-03-31
Reported value
$3.2B
Quarter over quarter
-5.2%
Holdings
115
Top-10 concentration
39.7%
Filing Structure
Reports holdings for
- Verition Fund Management LLC · File #028-13309 · since Q4 2018
Holdings reported by
- Verition Fund Management LLC · Q1 2019 – Q3 2024 · declared by one filing
Key People
Form ADV owners & control persons
Kai N/a Zheng
OWNER
Scott B Arneill
CHIEF MARKETING OFFICER
Suzanne Leigh Horowitz
CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2021 13F record
Q4 2021 13F filing summary
| Period of report | December 31, 2021 |
|---|---|
| Filed | February 14, 2022 |
| Form | 13F-HR |
| Reported value | $3.2B |
| Positions | 115 |
| Change in reported value | -4.0% |
| New positions | 69 |
| Exited positions | 70 |
| Position turnover | 75.1% |
| Top-10 concentration | 39.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
24 | $3.3B |
|
Q1 2026 13F
Filed May 15, 2026
|
16 | $3.1B |
|
Q4 2025 13F
Filed Feb 13, 2026
|
16 | $3.1B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
20 | $3.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
35 | $3.0B |
|
Q1 2025 13F
Filed May 15, 2025
|
40 | $3.3B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
28 | $3.2B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
25 | $3.3B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
19 | $2.5B |
|
Q1 2024 13F
Filed May 15, 2024
|
21 | $2.6B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
15 | $2.8B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
19 | $2.3B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
14 | $2.5B |
|
Q1 2023 13F
Filed May 15, 2023
|
18 | $2.6B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
56 | $2.6B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
98 | $2.6B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
105 | $2.5B |
|
Q1 2022 13F
Filed May 16, 2022
|
109 | $3.2B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
115 | $3.2B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
126 | $3.4B |
11 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | TSLA TESLA INC | $256.7M | 7.98% |
| 2 | DXCM 0.75 12/01/23 DEXCOM INC | $154.8M | 4.81% |
| 3 | SEALTD 1 12/01/24 SEA LTD | $150.0M | 4.66% |
| 4 | ZS 0.125 07/01/25 ZSCALER INC | $127.9M | 3.97% |
| 5 | BILI 1.375 04/01/26 BILIBILI INC | $121.3M | 3.77% |
| 6 | SRPT SAREPTA THERAPEUTICS INC | $120.6M | 3.75% |
| 7 | XYZ 0.125 03/01/25 BLOCK INC | $99.6M | 3.1% |
| 8 | SEDG 0 09/15/25 SOLAREDGE TECHNOLOGIES INC | $94.1M | 2.92% |
| 9 | VNE 4 06/01/24 VEONEER INC | $77.5M | 2.41% |
| 10 | BILL 0 12/01/25 BILL COM HLDGS INC | $74.8M | 2.32% |
| 11 | RGEN 0.375 07/15/24 REPLIGEN CORP | $70.9M | 2.2% |
| 12 | PSTG 0.125 04/15/23 PURE STORAGE INC | $66.0M | 2.05% |
| 13 | IONS 0.125 12/15/24 IONIS PHARMACEUTICALS INC | $65.0M | 2.02% |
| 14 | NTNX 0 01/15/23 NUTANIX INC | $58.5M | 1.82% |
| 15 | PD 1.25 07/01/25 PAGERDUTY INC | $58.4M | 1.81% |
| 16 | LTHM 4.125 07/15/25 LIVENT CORP | $55.1M | 1.71% |
| 17 | DDOG 0.125 06/15/25 DATADOG INC | $54.1M | 1.68% |
| 18 | PCRX 2.375 04/01/22 PACIRA BIOSCIENCES INC | $50.0M | 1.55% |
| 19 | TVTX 2.5 09/15/25 TRAVERE THERAPEUTICS INC | $49.2M | 1.53% |
| 20 | SEALTD 2.375 12/01/25 SEA LTD | $46.0M | 1.43% |
Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.